2020
DOI: 10.1128/aac.01444-19
|View full text |Cite
|
Sign up to set email alerts
|

Lead Optimization of Dehydroemetine for Repositioned Use in Malaria

Abstract: Drug repositioning offers an effective alternative to de novo drug design to tackle the urgent need for novel antimalarial treatments. The antiamoebic compound emetine dihydrochloride has been identified as a potent in vitro inhibitor of the multidrug-resistant strain K1 of Plasmodium falciparum (50% inhibitory concentration [IC 50 ], 47 nM Ϯ 2.1 nM [mean Ϯ standard deviation]). Dehydroemetine, a synthetic analogue of emetine dihydrochloride, has been reported to have lesscardiotoxic effects than emetine. The … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 53 publications
0
7
0
Order By: Relevance
“…The ribosome is a frequent target of small molecules produced by a variety of microorganisms. Ribosome targeting molecules are widely used in biomedical research to experimentally modulate translation elongation dynamics and also as therapeutic agents in the clinic (Carocci and Yang, 2016; Lin et al, 2018; Panwar et al, 2020). While the precise mechanism of action has been resolved from a structural perspective for a small number of ribosome targeting drugs (i.e., identification of the binding site on ribosomes (Garreau de Loubresse et al, 2014; Schneider-Poetsch et al, 2010)), the effects of these drugs on translation elongation dynamics in vivo are poorly understood.…”
Section: Resultsmentioning
confidence: 99%
“…The ribosome is a frequent target of small molecules produced by a variety of microorganisms. Ribosome targeting molecules are widely used in biomedical research to experimentally modulate translation elongation dynamics and also as therapeutic agents in the clinic (Carocci and Yang, 2016; Lin et al, 2018; Panwar et al, 2020). While the precise mechanism of action has been resolved from a structural perspective for a small number of ribosome targeting drugs (i.e., identification of the binding site on ribosomes (Garreau de Loubresse et al, 2014; Schneider-Poetsch et al, 2010)), the effects of these drugs on translation elongation dynamics in vivo are poorly understood.…”
Section: Resultsmentioning
confidence: 99%
“…The antiparasitic activities of emetine and DHE are attributed to inhibition of protein synthesis ( Entner and Grollman, 1973 ). Emetine and DHE interact with the E-site located in the 40S subunit of the Plasmodium falciparum ribosome and thereby inhibit peptide chain translocation ( Wong et al., 2014 ; Dmitriev et al., 2020 ; Panwar et al., 2020 ). In contrast, there is minimal consensus on how these therapeutic agents exert their biological activity as antiviral drugs.…”
Section: Discussionmentioning
confidence: 99%
“…The synthetic analog, dehydroemetine (DHE), elicits lower cardiotoxicity than emetine ( Dempsey and Salem, 1966 ), presumably due to a shorter half-life in heart tissues ( Schwartz and Herrero, 1965 ). Due to its reduced cardiotoxicity, potent activity against Plasmodium species, and its in vitro synergism with chloroquine ( Wong et al., 2014 ), atovaquone, and proguanil ( Panwar et al., 2020 ) in vitro , DHE has been considered for the treatment of malaria ( Wong et al., 2014 ; Panwar et al., 2020 ). The effectiveness of DHE as an antiviral agent for the treatment of coronavirus diseases is yet to be established.…”
Section: Introductionmentioning
confidence: 99%
“…The effect of the B. carterii oleoresin methanolic extract on leukaemia mitochondrial membrane potential (Δψ m ) was evaluated by flow cytometry as previously described by Panwar et al (2020) . Cell densities of 100,000 cells were incubated for 24–72 h with 25–100 μg/ml B. carterii oleoresin extract, a vehicle control (0.5% v/v DMSO) or a positive control (the oxidative phosphorylation uncoupler carbonyl cyanide 3-chlorophenylhydrazone (CCCP) (Sigma Aldrich, United States).…”
Section: Methodsmentioning
confidence: 99%